000			01032nam a2200301 a 4500
005			20250914131754.0
008			031201s2002 xxka 001 0 eng d
020			_a1853179256 _cRM253.01
039		9	_a200407201821 _blailawati _c200404080921 _drapiza _y12-01-2003 _zratnab
060			_aQV77
090			_aQV77.P536 2002 [00002147747]
245	0	0	_aPharmacoeconomics in psychiatry / _cedited by David Taylor, Martin Knapp, Robert Kerwin
260			_aLondon : _bMartin Dunitz, _c2002
300			_axii, 107 p. : _bill. ; _c21 cm.
650	1	2	_aPsychopharmacology _xEconomic aspects
650	2	2	_aDrugs _xPrescribing _xEconomic aspects
650	2	2	_aDrugs _xCost effectiveness
700	1		_aTaylor, David
700	1		_aKerwin, Robert
700	1		_aKnapp, Martin
907			_a.b13303247 _b2019-11-12 _c2019-11-12
942			_c01 _n0 _kQV77.P536 2002 [00002147747]
914			_avtls000345096
990			_azaa
991			_aJabatan Bioperubatan
998			_ad _b2003-01-12 _cm _da _feng _gxxk _y0 _z.b13303247
999			_c329778 _d329778